Colon cancer and lung cancer tissue array |
|
CLC601 |
TissueArray |
each |
EUR 306 |
|
Description: Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases/60 cores |
Human IgG antibody Laboratories manufactures the nanoprobes and pancreati cancer reagents distributed by Genprice. The Nanoprobes And Pancreati Cancer reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Nanoprobes Ltd. Nanogold. Other Nanoprobes products are available in stock. Specificity: Nanoprobes Category: And Group: Pancreati Cancer
Bladder cancer and bladder tissue array |
|
TissueArray |
each |
EUR 306 |
|
Description: Bladder cancer and bladder tissue array, including pathology grade, TNM and clinical stage, 60 cases/80 cores, replacing BL806a |
Breast cancer and normal tissue array |
|
TissueArray |
each |
EUR 414 |
|
Description: Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases/96 cores |
Breast cancer and normal tissue array |
|
TissueArray |
each |
EUR 306 |
|
Description: Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replaced by BR8015 |
Esophagus cancer and esophagus tissue array |
|
TissueArray |
each |
EUR 546 |
|
Description: Esophagus cancer and esophagus tissue array, with metastatic cancer, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing ES208 |
Esophagus cancer and normal tissue array |
|
TissueArray |
each |
EUR 306 |
|
Description: Esophagus cancer and normal tissue array, with grade and stage data, 40 cases/80 cores |
Esophagus cancer and normal tissue array |
|
TissueArray |
each |
EUR 306 |
|
Description: Esophagus cancer and normal tissue array, with TNM and grade info, 78 cases/80 cores |
Esophageal cancer and adjacent tissue array |
|
TissueArray |
each |
EUR 270 |
|
Description: Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases/72 cores, replacing BC02023 |
Pancreati Cancer information
Human Pancreatic Cancer (single section per slide) (5 slides/pack) |
|
HuCAT166 |
TissueArray |
5 slides |
EUR 150 |
Human Pancreatic Cancer (single section per slide) (5 slides/pack) |
|
HuCAT167 |
TissueArray |
5 slides |
EUR 150 |
Human Pancreatic Cancer (single section per slide) (5 slides/pack) |
|
HuCAT171 |
TissueArray |
5 slides |
EUR 150 |
Human Pancreatic Cancer (single section per slide) (5 slides/pack) |
|
HuCAT176 |
TissueArray |
5 slides |
EUR 150 |
Human Cancer PrimaCell13: Pancreatic Tumor Cells Growth Medium |
|
9-46036 |
CHI Scientific |
5 x 100 ml |
Ask for price |
Human Pancreatic & GI Cancer (CA199) ELISA Kit, 96 tests, Quantitative |
|
1840 |
Alpha Diagnostics |
1 kit |
EUR 781.2 |
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker)(CPA1/2711), 0.2mg/mL |
|
BNUB2711-100 |
Biotium |
1uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker)(CPA1/2711), 0.2mg/mL |
|
BNUB2711-500 |
Biotium |
1uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker)(CPA1/2712), 0.2mg/mL |
|
BNUB2712-100 |
Biotium |
1uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker)(CPA1/2712), 0.2mg/mL |
|
BNUB2712-500 |
Biotium |
1uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker)(CPA1/2713), 0.2mg/mL |
|
BNUB2713-100 |
Biotium |
1uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker)(CPA1/2713), 0.2mg/mL |
|
BNUB2713-500 |
Biotium |
1uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker)(CPA1/2714), 0.2mg/mL |
|
BNUB2714-100 |
Biotium |
1uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker)(CPA1/2714), 0.2mg/mL |
|
BNUB2714-500 |
Biotium |
1uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker)(CPA1/2711), 1mg/mL |
|
BNUM2711-50 |
Biotium |
1uL |
EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker)(CPA1/2712), 1mg/mL |
|
BNUM2712-50 |
Biotium |
1uL |
EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker)(CPA1/2713), 1mg/mL |
|
BNUM2713-50 |
Biotium |
1uL |
EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
